-transparent.png){kind=logo}
Podophyllotoxin and its derivatives were examined for inhibitory effects on the replication of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2), including acyclovir-resistant virus and clinical isolates. Deoxypodophyllotoxin (RD4-6266) proved to be a highly potent and selective inhibitor of all HSV strains in MRC-5 cells. EC50 values of RD4-6283 (in which the methylenedioxy ring A is modified) for HSV-1 and -2 were inferior to those of deoxypodophyllotoxin. However, podorhizol (RD4-6277) and 5'-methoxy-podorhizol (RD4-6276), in which ring C is absent, did not inhibit HSV replication. Moreover, RD4-6266 also inhibited the production of infectious virus particles of HSV-1 KOS strain and HSV-2 G strain. In contrast, none of the podophyllotoxin derivatives were found to have an antiviral effect against influenza A virus, respiratory syncytial virus or human cytomegalovirus in doses not toxic to the cells.
K Sudo, and
K Konno, and
S Shigeta, and
T Yokota
November 1976,
The Journal of general virology,
K Sudo, and
K Konno, and
S Shigeta, and
T Yokota
January 1995,
Archives of virology,
K Sudo, and
K Konno, and
S Shigeta, and
T Yokota
January 1997,
Annual review of biochemistry,
K Sudo, and
K Konno, and
S Shigeta, and
T Yokota
October 1992,
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
K Sudo, and
K Konno, and
S Shigeta, and
T Yokota
February 1995,
Journal of chemotherapy (Florence, Italy),
K Sudo, and
K Konno, and
S Shigeta, and
T Yokota
March 1976,
Virology,
K Sudo, and
K Konno, and
S Shigeta, and
T Yokota
April 1973,
Virology,
K Sudo, and
K Konno, and
S Shigeta, and
T Yokota
September 1999,
Antiviral research,
K Sudo, and
K Konno, and
S Shigeta, and
T Yokota
January 2008,
Natural product research,
K Sudo, and
K Konno, and
S Shigeta, and
T Yokota
January 2001,
The American journal of Chinese medicine,
